94 related articles for article (PubMed ID: 26672658)
1. [Locked outside: cure of chronic hepatitis C using an entry inhibitor].
Mailly L; Zeisel MB; Baumert TF
Med Sci (Paris); 2015 Dec; 31(12):1075-7. PubMed ID: 26672658
[No Abstract] [Full Text] [Related]
2. ["Entry inhibitors" prevent virus access to the cell]].
Fessler B
MMW Fortschr Med; 2015 Mar; 157 Suppl 1():86. PubMed ID: 26012995
[No Abstract] [Full Text] [Related]
3. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
[TBL] [Abstract][Full Text] [Related]
4. [HCV entry as a new therapeutic target in chronic hepatitis C].
Dabrowska MM; Panasiuk A; Flisiak R
Pol Merkur Lekarski; 2009 Aug; 27(158):140-3. PubMed ID: 19856882
[TBL] [Abstract][Full Text] [Related]
5. Dual blockade of hepatitis C virus entry at a gatekeeper of hepatocytes: Not only a preventive, but also therapeutic target of claudin 1.
Sugiyama M; Kanto T
Hepatology; 2016 Sep; 64(3):979-82. PubMed ID: 27405253
[No Abstract] [Full Text] [Related]
6. Emerging host cell targets for hepatitis C therapy.
He Y; Duan W; Tan SL
Drug Discov Today; 2007 Mar; 12(5-6):209-17. PubMed ID: 17331885
[TBL] [Abstract][Full Text] [Related]
7. Overcoming the roadblocks in hepatitis C virus infection.
Baumert TF; Zeuzem S
J Hepatol; 2014 Nov; 61(1 Suppl):S1-2. PubMed ID: 25443338
[No Abstract] [Full Text] [Related]
8. Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.
Fukasawa M; Nagase S; Shirasago Y; Iida M; Yamashita M; Endo K; Yagi K; Suzuki T; Wakita T; Hanada K; Kuniyasu H; Kondoh M
J Virol; 2015 May; 89(9):4866-79. PubMed ID: 25673725
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiology of hepatitis C and vaccine perspectives].
Nau JY
Rev Med Suisse; 2016 Jan; 12(503):234-5. PubMed ID: 26939196
[No Abstract] [Full Text] [Related]
10. Prevention and treatment of hepatitis C virus recurrence after liver transplantation.
Garcia-Retortillo M; Forns X
J Hepatol; 2004 Jul; 41(1):2-10. PubMed ID: 15246200
[No Abstract] [Full Text] [Related]
11. Aspirin inhibits hepatitis C virus entry by downregulating claudin-1.
Yin P; Zhang L
J Viral Hepat; 2016 Jan; 23(1):62-4. PubMed ID: 26289738
[TBL] [Abstract][Full Text] [Related]
12. Present and future therapy for hepatitis C virus.
Cornberg M; Deterding K; Manns MP
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):781-93. PubMed ID: 17140355
[TBL] [Abstract][Full Text] [Related]
13. The science of direct-acting antiviral and host-targeted agent therapy.
Pawlotsky JM
Antivir Ther; 2012; 17(6 Pt B):1109-17. PubMed ID: 23188746
[TBL] [Abstract][Full Text] [Related]
14. The end of hepatitis C.
Sussman NL; Remien CH; Kanwal F
Clin Gastroenterol Hepatol; 2014 Apr; 12(4):533-6. PubMed ID: 24480676
[No Abstract] [Full Text] [Related]
15. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.
Volz T; Allweiss L; Ben MBarek M; Warlich M; Lohse AW; Pollok JM; Alexandrov A; Urban S; Petersen J; Lütgehetmann M; Dandri M
J Hepatol; 2013 May; 58(5):861-7. PubMed ID: 23246506
[TBL] [Abstract][Full Text] [Related]
16. Strategies to inhibit entry of HBV and HDV into hepatocytes.
Urban S; Bartenschlager R; Kubitz R; Zoulim F
Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
[TBL] [Abstract][Full Text] [Related]
17. Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication.
Li S; Kodama EN; Inoue Y; Tani H; Matsuura Y; Zhang J; Tanaka T; Hattori T
Antivir Chem Chemother; 2010 Aug; 20(6):239-48. PubMed ID: 20710064
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C treatment options improving.
Mayo Clin Health Lett; 2013 Jan; 31(1):4. PubMed ID: 23565562
[No Abstract] [Full Text] [Related]
19. [Novel strategies for preventing viral hepatitis C recurrence after liver transplantation].
Stoll-Keller F; Fafi-Kremer S; Wolf P; Doffoël M; Baumert T
Bull Acad Natl Med; 2008 Nov; 192(8):1657-67; discussion 1667-8. PubMed ID: 19445379
[TBL] [Abstract][Full Text] [Related]
20. How does interferon inhibit HCV cell entry?
Jones M; Owen JS
Gut; 2008 May; 57(5):573-4. PubMed ID: 18408099
[No Abstract] [Full Text] [Related]
[Next] [New Search]
